Functional T Cell Reconstitution and Human Immunodeficiency Virus—1—Specific Cell-Mediated Immunity during Highly Active Antiretroviral Therapy

Lymphoproliferative responses (LPRs) to recall antigens (Ags) and human immunodeficiency virus type 1 (HIV-1) Gag and frequencies of circulating HIV-1—specific cytotoxic T lymphocyte precursors (CTLps) were measured in 12 patients undergoing highly active antiretroviral therapy (HAART) after long-st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 1999-07, Vol.180 (1), p.76-86
Hauptverfasser: Pontesilli, Oscar, Kerkhof-Garde, Susana, Notermans, Daan W., Foudraine, Norbert A., Roos, Marijke T. L., Klein, Michèl R., Danner, Sven A., Lange, Joep M. A., Miedema, Frank
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 86
container_issue 1
container_start_page 76
container_title The Journal of infectious diseases
container_volume 180
creator Pontesilli, Oscar
Kerkhof-Garde, Susana
Notermans, Daan W.
Foudraine, Norbert A.
Roos, Marijke T. L.
Klein, Michèl R.
Danner, Sven A.
Lange, Joep M. A.
Miedema, Frank
description Lymphoproliferative responses (LPRs) to recall antigens (Ags) and human immunodeficiency virus type 1 (HIV-1) Gag and frequencies of circulating HIV-1—specific cytotoxic T lymphocyte precursors (CTLps) were measured in 12 patients undergoing highly active antiretroviral therapy (HAART) after long-standing HIV-1 infection. LPRs to at least 1 recall Ag became detectable or increased in all patients during HAART. No significant LPRs to Gag-p24 were observed, whereas 4 of 8 patients tested presented with Gag-p17—specific LPRs. HIV-1—specific CTLp frequencies became measurable or increased early during therapy in 6 of 10 patients tested and were maintained or decreased thereafter. Increasing HIV-1—specific CTLp frequencies were seen only in association with partial HAART failure in 1 patient. In conclusion, restoration of CD4+ T lymphocyte responsiveness to recall Ags is achieved during HAART. The data provide evidence for limited HIV-1—specific CD4+ memory T cells during advanced HIV-1 infection and suggest that both CD4+ and CD8+ HIV-1—specific T cells are poorly stimulated when viral load is suppressed.
doi_str_mv 10.1086/314837
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_69797375</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30109102</jstor_id><sourcerecordid>30109102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c454t-4dc05c8db884cf6aeaa240ab67c9da6fdfd377df793f186129a95c6a1a39fa793</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSMEokOBNwBZCLEL2HHin-VoREnRIChTEGJjeWyn9ZA4g38qZsc7wBPyJHjIqEVsWFhXuufz8fU9RfEQwecIMvICo5phequYoQbTkhCEbxczCKuqRIzzo-JeCBsIYY0JvVscIYgbzEg9K36cJKeiHZ3swTlYmL4H740aXYg2pn0fSKdBmwbpwOkwJDdq01lljVM78NH6FH59_4nyWW2Nsln541G-MdrKaPR0x8Yd0MlbdwFae3HZ78A8v3llwNxF603045X1-wEujZfb3f3iTif7YB4c6nHx4eTl-aItl29fnS7my1LVTR3LWivYKKbXjNWqI9JIWdVQrglVXEvS6U5jSnVHOe4QI6jikjeKSCQx72TuHhfPJt-tH78mE6IYbFB5fOnMmIIgnHKKafNfELEKN5zVGXzyD7gZk8-7DaKqMIcEQnbjpvwYgjed2Ho7SL8TCIp9mGIKM4OPD25pPRj9Fzall4GnB0AGJfvOS6dsuOFYAytKMvZowjYhjv5axhBBjmCV9XLSbYjm27Uu_RdB9v8X7afPYrl69_qMrc5Ei38DaGDCtA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223906008</pqid></control><display><type>article</type><title>Functional T Cell Reconstitution and Human Immunodeficiency Virus—1—Specific Cell-Mediated Immunity during Highly Active Antiretroviral Therapy</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><creator>Pontesilli, Oscar ; Kerkhof-Garde, Susana ; Notermans, Daan W. ; Foudraine, Norbert A. ; Roos, Marijke T. L. ; Klein, Michèl R. ; Danner, Sven A. ; Lange, Joep M. A. ; Miedema, Frank</creator><creatorcontrib>Pontesilli, Oscar ; Kerkhof-Garde, Susana ; Notermans, Daan W. ; Foudraine, Norbert A. ; Roos, Marijke T. L. ; Klein, Michèl R. ; Danner, Sven A. ; Lange, Joep M. A. ; Miedema, Frank</creatorcontrib><description>Lymphoproliferative responses (LPRs) to recall antigens (Ags) and human immunodeficiency virus type 1 (HIV-1) Gag and frequencies of circulating HIV-1—specific cytotoxic T lymphocyte precursors (CTLps) were measured in 12 patients undergoing highly active antiretroviral therapy (HAART) after long-standing HIV-1 infection. LPRs to at least 1 recall Ag became detectable or increased in all patients during HAART. No significant LPRs to Gag-p24 were observed, whereas 4 of 8 patients tested presented with Gag-p17—specific LPRs. HIV-1—specific CTLp frequencies became measurable or increased early during therapy in 6 of 10 patients tested and were maintained or decreased thereafter. Increasing HIV-1—specific CTLp frequencies were seen only in association with partial HAART failure in 1 patient. In conclusion, restoration of CD4+ T lymphocyte responsiveness to recall Ags is achieved during HAART. The data provide evidence for limited HIV-1—specific CD4+ memory T cells during advanced HIV-1 infection and suggest that both CD4+ and CD8+ HIV-1—specific T cells are poorly stimulated when viral load is suppressed.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1086/314837</identifier><identifier>PMID: 10353864</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Adult ; AIDS ; AIDS/HIV ; Anti-HIV Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Biological and medical sciences ; Gene Products, gag - immunology ; Highly active antiretroviral therapy ; HIV 1 ; HIV Infections - drug therapy ; HIV Infections - immunology ; HIV Reverse Transcriptase - immunology ; HIV-1 - immunology ; Human immunodeficiency virus 1 ; Human viral diseases ; Humans ; Immunity, Cellular ; Infections ; Infectious diseases ; Longitudinal Studies ; Lymphocytes ; Major Articles ; Male ; Medical sciences ; Memory recall ; Middle Aged ; Pharmacology. Drug treatments ; RNA ; T lymphocytes ; T-Lymphocytes, Cytotoxic - immunology ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Viral load ; Viruses</subject><ispartof>The Journal of infectious diseases, 1999-07, Vol.180 (1), p.76-86</ispartof><rights>Copyright 1999 Infectious Diseases Society of America</rights><rights>1999 INIST-CNRS</rights><rights>Copyright University of Chicago, acting through its Press Jul 1999</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c454t-4dc05c8db884cf6aeaa240ab67c9da6fdfd377df793f186129a95c6a1a39fa793</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30109102$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30109102$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1850276$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10353864$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pontesilli, Oscar</creatorcontrib><creatorcontrib>Kerkhof-Garde, Susana</creatorcontrib><creatorcontrib>Notermans, Daan W.</creatorcontrib><creatorcontrib>Foudraine, Norbert A.</creatorcontrib><creatorcontrib>Roos, Marijke T. L.</creatorcontrib><creatorcontrib>Klein, Michèl R.</creatorcontrib><creatorcontrib>Danner, Sven A.</creatorcontrib><creatorcontrib>Lange, Joep M. A.</creatorcontrib><creatorcontrib>Miedema, Frank</creatorcontrib><title>Functional T Cell Reconstitution and Human Immunodeficiency Virus—1—Specific Cell-Mediated Immunity during Highly Active Antiretroviral Therapy</title><title>The Journal of infectious diseases</title><addtitle>The Journal of Infectious Diseases</addtitle><description>Lymphoproliferative responses (LPRs) to recall antigens (Ags) and human immunodeficiency virus type 1 (HIV-1) Gag and frequencies of circulating HIV-1—specific cytotoxic T lymphocyte precursors (CTLps) were measured in 12 patients undergoing highly active antiretroviral therapy (HAART) after long-standing HIV-1 infection. LPRs to at least 1 recall Ag became detectable or increased in all patients during HAART. No significant LPRs to Gag-p24 were observed, whereas 4 of 8 patients tested presented with Gag-p17—specific LPRs. HIV-1—specific CTLp frequencies became measurable or increased early during therapy in 6 of 10 patients tested and were maintained or decreased thereafter. Increasing HIV-1—specific CTLp frequencies were seen only in association with partial HAART failure in 1 patient. In conclusion, restoration of CD4+ T lymphocyte responsiveness to recall Ags is achieved during HAART. The data provide evidence for limited HIV-1—specific CD4+ memory T cells during advanced HIV-1 infection and suggest that both CD4+ and CD8+ HIV-1—specific T cells are poorly stimulated when viral load is suppressed.</description><subject>Adult</subject><subject>AIDS</subject><subject>AIDS/HIV</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Gene Products, gag - immunology</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV 1</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - immunology</subject><subject>HIV Reverse Transcriptase - immunology</subject><subject>HIV-1 - immunology</subject><subject>Human immunodeficiency virus 1</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunity, Cellular</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Longitudinal Studies</subject><subject>Lymphocytes</subject><subject>Major Articles</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory recall</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>RNA</subject><subject>T lymphocytes</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Viral load</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhSMEokOBNwBZCLEL2HHin-VoREnRIChTEGJjeWyn9ZA4g38qZsc7wBPyJHjIqEVsWFhXuufz8fU9RfEQwecIMvICo5phequYoQbTkhCEbxczCKuqRIzzo-JeCBsIYY0JvVscIYgbzEg9K36cJKeiHZ3swTlYmL4H740aXYg2pn0fSKdBmwbpwOkwJDdq01lljVM78NH6FH59_4nyWW2Nsln541G-MdrKaPR0x8Yd0MlbdwFae3HZ78A8v3llwNxF603045X1-wEujZfb3f3iTif7YB4c6nHx4eTl-aItl29fnS7my1LVTR3LWivYKKbXjNWqI9JIWdVQrglVXEvS6U5jSnVHOe4QI6jikjeKSCQx72TuHhfPJt-tH78mE6IYbFB5fOnMmIIgnHKKafNfELEKN5zVGXzyD7gZk8-7DaKqMIcEQnbjpvwYgjed2Ho7SL8TCIp9mGIKM4OPD25pPRj9Fzall4GnB0AGJfvOS6dsuOFYAytKMvZowjYhjv5axhBBjmCV9XLSbYjm27Uu_RdB9v8X7afPYrl69_qMrc5Ei38DaGDCtA</recordid><startdate>19990701</startdate><enddate>19990701</enddate><creator>Pontesilli, Oscar</creator><creator>Kerkhof-Garde, Susana</creator><creator>Notermans, Daan W.</creator><creator>Foudraine, Norbert A.</creator><creator>Roos, Marijke T. L.</creator><creator>Klein, Michèl R.</creator><creator>Danner, Sven A.</creator><creator>Lange, Joep M. A.</creator><creator>Miedema, Frank</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19990701</creationdate><title>Functional T Cell Reconstitution and Human Immunodeficiency Virus—1—Specific Cell-Mediated Immunity during Highly Active Antiretroviral Therapy</title><author>Pontesilli, Oscar ; Kerkhof-Garde, Susana ; Notermans, Daan W. ; Foudraine, Norbert A. ; Roos, Marijke T. L. ; Klein, Michèl R. ; Danner, Sven A. ; Lange, Joep M. A. ; Miedema, Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c454t-4dc05c8db884cf6aeaa240ab67c9da6fdfd377df793f186129a95c6a1a39fa793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>AIDS</topic><topic>AIDS/HIV</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Gene Products, gag - immunology</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV 1</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - immunology</topic><topic>HIV Reverse Transcriptase - immunology</topic><topic>HIV-1 - immunology</topic><topic>Human immunodeficiency virus 1</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunity, Cellular</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Longitudinal Studies</topic><topic>Lymphocytes</topic><topic>Major Articles</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory recall</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>RNA</topic><topic>T lymphocytes</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Viral load</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pontesilli, Oscar</creatorcontrib><creatorcontrib>Kerkhof-Garde, Susana</creatorcontrib><creatorcontrib>Notermans, Daan W.</creatorcontrib><creatorcontrib>Foudraine, Norbert A.</creatorcontrib><creatorcontrib>Roos, Marijke T. L.</creatorcontrib><creatorcontrib>Klein, Michèl R.</creatorcontrib><creatorcontrib>Danner, Sven A.</creatorcontrib><creatorcontrib>Lange, Joep M. A.</creatorcontrib><creatorcontrib>Miedema, Frank</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pontesilli, Oscar</au><au>Kerkhof-Garde, Susana</au><au>Notermans, Daan W.</au><au>Foudraine, Norbert A.</au><au>Roos, Marijke T. L.</au><au>Klein, Michèl R.</au><au>Danner, Sven A.</au><au>Lange, Joep M. A.</au><au>Miedema, Frank</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional T Cell Reconstitution and Human Immunodeficiency Virus—1—Specific Cell-Mediated Immunity during Highly Active Antiretroviral Therapy</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>The Journal of Infectious Diseases</addtitle><date>1999-07-01</date><risdate>1999</risdate><volume>180</volume><issue>1</issue><spage>76</spage><epage>86</epage><pages>76-86</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>Lymphoproliferative responses (LPRs) to recall antigens (Ags) and human immunodeficiency virus type 1 (HIV-1) Gag and frequencies of circulating HIV-1—specific cytotoxic T lymphocyte precursors (CTLps) were measured in 12 patients undergoing highly active antiretroviral therapy (HAART) after long-standing HIV-1 infection. LPRs to at least 1 recall Ag became detectable or increased in all patients during HAART. No significant LPRs to Gag-p24 were observed, whereas 4 of 8 patients tested presented with Gag-p17—specific LPRs. HIV-1—specific CTLp frequencies became measurable or increased early during therapy in 6 of 10 patients tested and were maintained or decreased thereafter. Increasing HIV-1—specific CTLp frequencies were seen only in association with partial HAART failure in 1 patient. In conclusion, restoration of CD4+ T lymphocyte responsiveness to recall Ags is achieved during HAART. The data provide evidence for limited HIV-1—specific CD4+ memory T cells during advanced HIV-1 infection and suggest that both CD4+ and CD8+ HIV-1—specific T cells are poorly stimulated when viral load is suppressed.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>10353864</pmid><doi>10.1086/314837</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1999-07, Vol.180 (1), p.76-86
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_69797375
source Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE
subjects Adult
AIDS
AIDS/HIV
Anti-HIV Agents - therapeutic use
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Biological and medical sciences
Gene Products, gag - immunology
Highly active antiretroviral therapy
HIV 1
HIV Infections - drug therapy
HIV Infections - immunology
HIV Reverse Transcriptase - immunology
HIV-1 - immunology
Human immunodeficiency virus 1
Human viral diseases
Humans
Immunity, Cellular
Infections
Infectious diseases
Longitudinal Studies
Lymphocytes
Major Articles
Male
Medical sciences
Memory recall
Middle Aged
Pharmacology. Drug treatments
RNA
T lymphocytes
T-Lymphocytes, Cytotoxic - immunology
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Viral load
Viruses
title Functional T Cell Reconstitution and Human Immunodeficiency Virus—1—Specific Cell-Mediated Immunity during Highly Active Antiretroviral Therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T00%3A45%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20T%20Cell%20Reconstitution%20and%20Human%20Immunodeficiency%20Virus%E2%80%941%E2%80%94Specific%20Cell-Mediated%20Immunity%20during%20Highly%20Active%20Antiretroviral%20Therapy&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Pontesilli,%20Oscar&rft.date=1999-07-01&rft.volume=180&rft.issue=1&rft.spage=76&rft.epage=86&rft.pages=76-86&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1086/314837&rft_dat=%3Cjstor_proqu%3E30109102%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223906008&rft_id=info:pmid/10353864&rft_jstor_id=30109102&rfr_iscdi=true